LTUS OTC
Lotus Pharmaceuticals, Inc.
1W: +8.4%
1M: +46.3%
3M: +41.6%
YTD: +46.3%
1Y: +29.1%
3Y: -26.8%
5Y: -87.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$19K
+19.7% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$19K
+19.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$748
+111.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$22K | -$6K | -$30K | -$21K | -$19K |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $0 | $0 | $0 | -$3K | -$320 |
| Other Non-Cash Items | $0 | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$22K | -$6K | -$30K | -$24K | -$19K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $9K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $9K | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $17K | $20K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $30K | $8K | $36K | $0 | $0 |
| Financing Cash Flow | $30K | $8K | $36K | $17K | $20K |
| Net Change in Cash | -$1M | $2K | $6K | -$7K | $748 |
| Cash End of Period | $31 | $2K | $8K | $1K | $2K |
| Free Cash Flow | -$22K | -$6K | -$30K | -$24K | -$19K |